MiMedx Group Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
Sales 2024 * | 36Cr 3.02TCr | Sales 2025 * | 41Cr 3.39TCr | Capitalization | 104.8Cr 8.75TCr |
---|---|---|---|---|---|
Net income 2024 * | 4.5Cr 375.77Cr | Net income 2025 * | 5.5Cr 459.27Cr | EV / Sales 2024 * | 2.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
17.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.64% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27/23/27 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05/23/05 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02/20/02 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08/21/08 |
K. Newton
BRD | Director/Board Member | 61 | 19/19/19 |
1st Jan change | Capi. | |
---|---|---|
-24.53% | 12Cr | |
-15.49% | 6.3Cr | |
0.00% | 5.75Cr | |
-8.98% | 5.07Cr |